False‑Negative HCV RNA Testing in Acute Hepatitis C

Timing of False‑Negative Results

• False‑negative HCV RNA tests are uncommon but clinically significant, occurring mainly during two windows: (1) the very early phase before viremia peaks (first 1–2 weeks after exposure) and (2) transiently during the acute phase as anti‑HCV antibodies rise and viral load declines. 1
• HCV RNA becomes detectable 1–3 weeks after exposure, whereas anti‑HCV antibodies typically appear 2–6 months after exposure. 1, 2
• In the first 1–2 weeks post‑exposure, even highly sensitive assays may fail to detect HCV RNA, representing a true pre‑viremic window. 1
• This early window is brief and is rarely encountered clinically unless testing is performed immediately after a known exposure. 2
• As anti‑HCV antibody titers increase during acute infection, HCV RNA titers can paradoxically decline, creating a transient period when RNA may be undetectable. 1, 3
• The transient RNA negativity can occur in patients with active acute infection, but chronic infection may still develop thereafter. 1, 3
• CDC guidelines state that HCV RNA may be undetectable in certain persons during the acute phase, but this finding can be transient and chronic infection can still develop. 1
• Intermittent HCV RNA positivity has been documented in both acute and chronic infection. 1, 3
• A single negative HCV RNA result does not definitively exclude active infection without additional clinical context. 1, 3
• Serial HCV RNA testing over time is necessary to confirm true viral clearance versus transient negativity. 3

Clinical Implications & Testing Strategy

• Recent exposure (≤ 6 months) warrants repeat RNA testing even if the initial result is negative. 2
• Immunocompromised patients may experience delayed or intermittent viremia and therefore require serial RNA testing. 1
• When acute HCV is suspected based on exposure history or clinical presentation, repeat HCV RNA testing should be performed even after an initial negative result. 1
• The optimal timing for repeat testing is > 1 month after the initial test to allow for seroconversion or viral rebound. 1
• Serial HCV RNA determinations are required to distinguish resolved infection from transient viral suppression. 1, 3
• Do not rely on a single negative HCV RNA test to exclude acute infection in patients with recent exposure or clinical hepatitis. 1
• Do not assume an antibody‑negative result rules out acute infection; HCV RNA can be positive for weeks before antibodies develop. 1, 2
• Do not interpret intermittent negative RNA results as definitive clearance without serial testing over several months. 1, 3

Special Populations

• In immunocompromised individuals, anti‑HCV may remain negative despite chronic infection; detection of HCV RNA may be the only evidence of infection. 1
• Serial RNA testing is essential in this population even when antibody results are negative. 1

Spontaneous Clearance Rates

• Among adults infected at older ages (> 45 years), 15–25 % spontaneously clear the infection. 1
• Among individuals infected as children or younger adults, 40–45 % achieve spontaneous clearance. 1
• Multiple negative RNA results over time are required to confirm true clearance versus intermittent negativity. 3

HCV Antibody Positive but HCV RNA Negative: Interpretation

Immediate Next Steps

• The American College of Obstetricians and Gynecologists recommends performing repeat HCV antibody testing using a different antibody assay platform to distinguish false-positive from cleared infection 4, 5, 6
• If the alternative assay is negative, the initial test was a false-positive, and no HCV infection is present, with no further evaluation needed 4, 5, 6
• If the alternative assay is positive, the infection has cleared, with approximately 20% of HCV infections spontaneously clearing 4, 5, 6

Clinical Interpretation

• The Centers for Disease Control and Prevention suggests that when both antibody tests are positive but HCV RNA is negative, this typically represents spontaneous viral clearance 7, 4
• Among adults who acquired HCV infection at older ages, 15-25% clear the infection, while 40-45% of those infected as children or younger adults clear the infection 8, 9
• Patients with cleared infections do not have active HCV infection and do not require antiviral treatment 7

Special Considerations

• The Centers for Disease Control and Prevention recommends considering repeating HCV RNA testing in specific circumstances, such as recent exposure within the past 6 months, clinical evidence of liver disease, concerns about specimen handling or storage, or immunocompromised patients 4, 5, 10
• HCV RNA can be intermittently positive in persons with chronic infection, and a single negative HCV RNA result does not definitively exclude active infection without additional clinical context 8, 9, 10

Counseling Points

• The Centers for Disease Control and Prevention advises informing patients with cleared infections that they do not have active HCV infection and do not need follow-up HCV testing 7
• Patients with false-positive results should be reassured that they are not infected with HCV, with no further HCV evaluation needed unless new risk exposures occur 7, 8

Common Pitfalls to Avoid

• The American College of Obstetricians and Gynecologists warns against assuming a single negative HCV RNA definitively rules out infection without confirmatory antibody testing on an alternative platform 8, 9, 10
• Unnecessary repeat testing should not be ordered in confirmed cleared infections, and recent acute infection should not be missed by failing to consider timing of exposure relative to testing 7, 4, 5, 10